Bimatoprost as a Treatment for Graves' Orbitopathy

Study overview

Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Johns Hopkins University,

Emily Li, MD, PRINCIPAL_INVESTIGATOR, Johns Hopkins University

Study Record Dates

2030-07-01